Biofrontera transfers clinical research to the U.S.

"We can be much more flexible in our strategy to expand our market presence in Europe thanks to the newly defined cost structure"

22-Feb-2024 - Biofrontera AG announces that Biofrontera AG and Biofrontera Inc. have agreed on an amendment to the existing license and supply agreement (LSA). This amendment provides that Biofrontera Inc. will take over the entire clinical development program, thus reducing the cost burden for Biofrontera ...

SAS accelerates delivery of novel medicines using AI and analytics

Cooperation with AstraZeneca for more innovation in clinical research

12-Oct-2023 - SAS, a leader in AI and analytics, is helping to revolutionize the use of clinical trial data so new medicines can be delivered to patients faster than before. After a thorough evaluation, SAS has been chosen by global biopharmaceutical company AstraZeneca to help increase efficiency and drive ...

'Skinny fat' in older adults may predict dementia, Alzheimer's risk

05-Jul-2018 - A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults. While sarcopenia, the loss of muscle tissue that is part of the natural aging process, as well as ...

Analysis shows lack of evidence that wearable biosensors improve patient outcomes

17-Jan-2018 - Wearable biosensors have grown increasingly popular as many people use them in wristbands or watches to count steps or track sleep. But there is not enough proof that these devices are improving patient outcomes such as weight or blood pressure, according to a study by Cedars-Sinai ...

Focus on Medical Device Regulation

BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM publish “MedTech Radar 9”

15-Nov-2017 - The EU Medical Device Regulation heralds a new era for the medical technology sector: in future, any company wishing to bring medical devices to market must face the requirements of this new regulatory framework. This implies a sizeable challenge for the many small and medium-sized enterprises in ...

Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

31-Aug-2017 - Thermo Fisher Scientific has formed the Immuno-Oncology Consortium to drive adoption of highly sensitive, next-generation sequencing (NGS) clinical research panels designed to help identify predictive and prognostic biomarkers associated with cancer immunotherapy. Recognizing this shift toward a ...

'Overturning established fact' leads to new new target in MLL-rearranged leukemia

15-Jun-2017 - The human gene MLL is named for the mixed lineage leukemia it creates. Specifically, the gene may break apart and fuse with parts from one of a number of other genes on other chromosomes to create cancer-causing translocations. These translocations make new proteins that have never been seen by ...

QIAGEN joins CANCER-ID consortium for liquid biopsy workflows

Public-private partnership aims to standardize and clinically validate blood-based biomarkers

31-Mar-2017 - QIAGEN N.V. announced it has joined CANCER-ID, a public-private consortium aiming to establish standard protocols and clinical validation for blood-based biomarkers in lung and breast cancer. Rapid advances in the use of liquid biopsies, which enable cancer treatment and monitoring through the ...

Supporting clinical research with an intensive-care database

Crowdsourcing clinical data from some 40,000 patients could vastly improve research and critical-care decisions

12-Jul-2016 - Critical care decisions in modern day intensive care units (ICUs) are made every day by doctors who rely on decades of studies and clinical trials to inform them of the most effective treatments for these patients, yet the amount of evidence supporting clinical decisions remains extremely low. A ...

'Recruitment by genotype' for genetic research poses ethical challenges, study finds

02-Jul-2012 - A potentially powerful strategy for studying the significance of human genetic variants is to recruit people identified by previous genetic research as having particular variants. But that strategy poses ethical challenges to informed consent, as well as potential risks to the people recruited, ...